202 related articles for article (PubMed ID: 33193091)
1. Increased Plasma Soluble Interleukin-2 Receptor Alpha Levels in Patients With Long-Term Type 1 Diabetes With Vascular Complications Associated With
Keindl M; Fedotkina O; du Plessis E; Jain R; Bergum B; Mygind Jensen T; Laustrup Møller C; Falhammar H; Nyström T; Catrina SB; Jörneskog G; Groop L; Eliasson M; Eliasson B; Brismar K; Nilsson PM; Berg TJ; Appel S; Lyssenko V
Front Endocrinol (Lausanne); 2020; 11():575469. PubMed ID: 33193091
[TBL] [Abstract][Full Text] [Related]
2. Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients.
Cerosaletti K; Schneider A; Schwedhelm K; Frank I; Tatum M; Wei S; Whalen E; Greenbaum C; Kita M; Buckner J; Long SA
PLoS One; 2013; 8(12):e83811. PubMed ID: 24376757
[TBL] [Abstract][Full Text] [Related]
3. Natural Variation in Interleukin-2 Sensitivity Influences Regulatory T-Cell Frequency and Function in Individuals With Long-standing Type 1 Diabetes.
Yang JH; Cutler AJ; Ferreira RC; Reading JL; Cooper NJ; Wallace C; Clarke P; Smyth DJ; Boyce CS; Gao GJ; Todd JA; Wicker LS; Tree TI
Diabetes; 2015 Nov; 64(11):3891-902. PubMed ID: 26224887
[TBL] [Abstract][Full Text] [Related]
4. The association of PTPN22 (rs2476601) and IL2RA (rs11594656) polymorphisms with T1D in Egyptian children.
Abdelrahman HM; Sherief LM; Abd Elrahman DM; Alghobashy A; Elsaadani HF; Mohamed RH
Hum Immunol; 2016 Aug; 77(8):682-686. PubMed ID: 27288719
[TBL] [Abstract][Full Text] [Related]
5. Serum level of soluble interleukin-2 receptor correlates with CD25 expression in patients with T lymphoblastic lymphoma.
Toji T; Takata K; Sato Y; Miyata-Takata T; Hayashi E; Habara T; Maeda Y; Tanimoto M; Yoshino T
J Clin Pathol; 2015 Aug; 68(8):622-7. PubMed ID: 25935549
[TBL] [Abstract][Full Text] [Related]
6. Impaired activation of STAT5 upon IL-2 stimulation in Tregs and elevated sIL-2R in Sjögren's syndrome.
Keindl M; Davies R; Bergum B; Brun JG; Hammenfors D; Jonsson R; Lyssenko V; Appel S
Arthritis Res Ther; 2022 May; 24(1):101. PubMed ID: 35526080
[TBL] [Abstract][Full Text] [Related]
7. Association between microfibrillar-associated protein 4 (MFAP4) and micro- and macrovascular complications in long-term type 1 diabetes mellitus.
Blindbæk SL; Schlosser A; Green A; Holmskov U; Sorensen GL; Grauslund J
Acta Diabetol; 2017 Apr; 54(4):367-372. PubMed ID: 28039584
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-7 receptor α-chain haplotypes differentially affect soluble IL-7 receptor and IL-7 serum concentrations in children with type 1 diabetes.
Seyfarth J; Lundtoft C; Förtsch K; Ahlert H; Rosenbauer J; Baechle C; Roden M; Holl RW; Mayatepek E; Kummer S; Meissner T; Jacobsen M
Pediatr Diabetes; 2018 Aug; 19(5):955-962. PubMed ID: 29484785
[TBL] [Abstract][Full Text] [Related]
9. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
[TBL] [Abstract][Full Text] [Related]
10. Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes.
Jain R; Özgümüş T; Jensen TM; du Plessis E; Keindl M; Møller CL; Falhammar H; Nyström T; Catrina SB; Jörneskog G; Jessen LE; Forsblom C; Haukka JK; Groop PH; Rossing P; Groop L; Eliasson M; Eliasson B; Brismar K; Al-Majdoub M; Nilsson PM; Taskinen MR; Ferrannini E; Spégel P; Berg TJ; Lyssenko V
Sci Rep; 2020 Jul; 10(1):11561. PubMed ID: 32665614
[TBL] [Abstract][Full Text] [Related]
11. An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4(+) T cells.
Long SA; Cerosaletti K; Wan JY; Ho JC; Tatum M; Wei S; Shilling HG; Buckner JH
Genes Immun; 2011 Mar; 12(2):116-25. PubMed ID: 21179116
[TBL] [Abstract][Full Text] [Related]
12. Type 1 diabetes linked PTPN22 gene polymorphism is associated with the frequency of circulating regulatory T cells.
Valta M; Gazali AM; Viisanen T; Ihantola EL; Ekman I; Toppari J; Knip M; Veijola R; Ilonen J; Lempainen J; Kinnunen T
Eur J Immunol; 2020 Apr; 50(4):581-588. PubMed ID: 31808541
[TBL] [Abstract][Full Text] [Related]
13. Study of polymorphisms in 4q27, 10p15, and 22q13 regions in autoantibodies stratified type 1 diabetes patients.
Espino-Paisán L; De La Calle H; Fernández-Arquero M; Figueredo MA; De La Concha EG; Urcelay E; Santiago JL
Autoimmunity; 2011 Dec; 44(8):624-30. PubMed ID: 21875375
[TBL] [Abstract][Full Text] [Related]
14. Association between mannose-binding lectin and vascular complications in type 1 diabetes.
Hansen TK; Tarnow L; Thiel S; Steffensen R; Stehouwer CD; Schalkwijk CG; Parving HH; Flyvbjerg A
Diabetes; 2004 Jun; 53(6):1570-6. PubMed ID: 15161763
[TBL] [Abstract][Full Text] [Related]
15. Genetic Variations of PTPN2 and PTPN22: Role in the Pathogenesis of Type 1 Diabetes and Crohn's Disease.
Sharp RC; Abdulrahim M; Naser ES; Naser SA
Front Cell Infect Microbiol; 2015; 5():95. PubMed ID: 26734582
[TBL] [Abstract][Full Text] [Related]
16.
Buhelt S; Laigaard HM; von Essen MR; Ullum H; Oturai A; Sellebjerg F; Søndergaard HB
Front Immunol; 2021; 12():676141. PubMed ID: 34386002
[TBL] [Abstract][Full Text] [Related]
17. The association between rs1893217, rs478582 in PTPN2 and T1D risk with different diagnosed age, and related clinical characteristics in Chinese Han population.
Chen S; Fan H; Feng Y; Zhang Y; Chen Y; Gu Y; Shi Y; Dai H; Zhang M; Xu X; Chen H; Yang T; Xu K
Autoimmunity; 2019 Mar; 52(2):95-101. PubMed ID: 31030572
[TBL] [Abstract][Full Text] [Related]
18. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes.
Lowe CE; Cooper JD; Brusko T; Walker NM; Smyth DJ; Bailey R; Bourget K; Plagnol V; Field S; Atkinson M; Clayton DG; Wicker LS; Todd JA
Nat Genet; 2007 Sep; 39(9):1074-82. PubMed ID: 17676041
[TBL] [Abstract][Full Text] [Related]
19. A cis-acting regulatory variant in the IL2RA locus.
Qu HQ; Verlaan DJ; Ge B; Lu Y; Lam KC; Grabs R; Harmsen E; Hudson TJ; Hakonarson H; Pastinen T; Polychronakos C
J Immunol; 2009 Oct; 183(8):5158-62. PubMed ID: 19794070
[TBL] [Abstract][Full Text] [Related]
20. IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production.
Maier LM; Lowe CE; Cooper J; Downes K; Anderson DE; Severson C; Clark PM; Healy B; Walker N; Aubin C; Oksenberg JR; Hauser SL; Compston A; Sawcer S; ; De Jager PL; Wicker LS; Todd JA; Hafler DA
PLoS Genet; 2009 Jan; 5(1):e1000322. PubMed ID: 19119414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
